Te Whatu Ora Waitaha, Christchurch, New Zealand.
University of Auckland, Auckland, New Zealand.
Arthritis Care Res (Hoboken). 2024 Mar;76(3):415-420. doi: 10.1002/acr.25250. Epub 2023 Dec 6.
In 2019, the Gout and Crystal Arthritis Network (G-CAN) published consensus statements for the nomenclature of disease elements and states in gout. The aim of this study was to determine adherence to the G-CAN consensus nomenclature statements since publication.
American College of Rheumatology and EULAR conference abstracts were searched using online databases for the keywords 'gout,' 'urate,' 'uric acid,' 'hyperuricaemia,' 'tophus,' and/or 'tophi' before and after publication of the consensus statements (January 1, 2016 to December 31, 2017 and January 1, 2020 to December 31, 2021, respectively). Abstracts were manually searched for labels used to reference gout disease elements and states. Use of the G-CAN-agreed labels, as well as alternatives, were compared between the two time periods.
There were 988 abstracts included in the analysis: 596 in 2016 to 2017 and 392 in 2020 to 2021. Use of the agreed labels 'urate' and 'gout flare' increased between the two periods. There were 219 of 383 abstracts (57.2%) with the agreed label 'urate' in 2016 to 2017 compared with 164 of 232 (70.7%) in 2020 to 2021 (P = 0.001). There were 60 of 175 abstracts (34.3%) with the agreed label 'gout flare' in 2016 to 2017 compared with 57 of 109 (52.3%) in 2020 to 2021 (P = 0.003). Consistent with the G-CAN statement, use of the label 'chronic gout' reduced between the two time periods. There were 29 of 596 abstracts (4.9%) in 2016 to 2017 that used the label 'chronic gout' compared with 8 of 392 abstracts (2.0%) in 2020 to 2021 (P = 0.02).
Use of G-CAN-agreed gout labels has increased, but gout nomenclature remains imprecise. Additional efforts are needed to ensure consistent use of agreed nomenclature for gout in the scientific literature.
2019 年，痛风和晶体关节炎网络（G-CAN）发布了痛风疾病要素和状态命名共识声明。本研究旨在确定自发表以来对 G-CAN 共识命名声明的遵守情况。
使用在线数据库，在发表共识声明之前（2016 年 1 月 1 日至 2017 年 12 月 31 日）和之后（2020 年 1 月 1 日至 2021 年 12 月 31 日），分别以“痛风”“尿酸”“尿酸盐”“高尿酸血症”“痛风石”和/或“痛风结节”为关键词，搜索美国风湿病学会和欧洲抗风湿病联盟会议摘要。对摘要进行手动搜索，以查找用于引用痛风疾病要素和状态的标签。比较了两个时期内使用 G-CAN 一致标签以及替代标签的情况。
共纳入 988 份摘要进行分析：2016 年至 2017 年有 596 份，2020 年至 2021 年有 392 份。两个时期内，一致标签“尿酸盐”和“痛风发作”的使用有所增加。在 2016 年至 2017 年的 383 份摘要中有 219 份（57.2%）使用了一致标签“尿酸盐”，而在 2020 年至 2021 年的 232 份摘要中有 164 份（70.7%）（P=0.001）。在 2016 年至 2017 年的 175 份摘要中有 60 份（34.3%）使用了一致标签“痛风发作”，而在 2020 年至 2021 年的 109 份摘要中有 57 份（52.3%）（P=0.003）。与 G-CAN 声明一致，两个时期内“慢性痛风”标签的使用有所减少。在 2016 年至 2017 年的 596 份摘要中有 29 份（4.9%）使用了“慢性痛风”标签，而在 2020 年至 2021 年的 392 份摘要中有 8 份（2.0%）（P=0.02）。
G-CAN 一致的痛风标签使用有所增加，但痛风命名仍不精确。需要进一步努力，确保在科学文献中痛风使用一致的命名。
